We are live on ! Find out more
WKA

Wilson Kemp & Associates Portfolio holdings

AUM $11M
1-Year Est. Return 17.37%
This Fund
S&P 500
This Quarter Est. Return
+2.86%
1 Year Est. Return
+17.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$45.4M
AUM Growth
-$59.1M
Cap. Flow
-$61.5M
Cap. Flow %
-135.52%
Top 10 Hldgs %
42%
Holding
89
New
Increased
Reduced
59
Closed
26

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$4.43M
2
IBM icon
IBM
IBM
+$4.09M
3
PEP icon
PepsiCo
PEP
+$2.94M
4
BA icon
Boeing
BA
+$2.17M
5
JNJ icon
Johnson & Johnson
JNJ
+$2.15M

Sector Composition

Rank Sector Weight
1 Consumer Staples 20%
2 Healthcare 18.25%
3 Technology 13.81%
4 Industrials 13.72%
5 Communication Services 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
1
Walmart Inc
WMT
$889B
$2.88M 6.35%
117,000
-81,102
-41% -$2.04M
IBM icon
2
IBM
IBM
$220B
$2.61M 5.76%
14,764
-22,521
-60% -$4.09M
PEP icon
3
PepsiCo
PEP
$188B
$2.07M 4.57%
26,075
-35,766
-58% -$2.94M
PFE icon
4
Pfizer
PFE
$147B
$1.97M 4.34%
72,372
-49,444
-41% -$1.35M
DIS icon
5
Walt Disney
DIS
$179B
$1.85M 4.07%
28,660
-7,492
-21% -$480K
MRK icon
6
Merck
MRK
$317B
$1.71M 3.76%
37,625
-37,239
-50% -$1.7M
XOM icon
7
ExxonMobil
XOM
$637B
$1.62M 3.57%
18,850
-49,139
-72% -$4.43M
GE icon
8
GE Aerospace
GE
$391B
$1.6M 3.53%
14,006
-15,840
-53% -$1.82M
ADP icon
9
Automatic Data Processing
ADP
$108B
$1.44M 3.17%
22,666
-23,520
-51% -$1.49M
BMY icon
10
Bristol-Myers Squibb
BMY
$130B
$1.3M 2.87%
28,160
-21,845
-44% -$959K
JNJ icon
11
Johnson & Johnson
JNJ
$617B
$1.29M 2.85%
14,939
-23,948
-62% -$2.15M
PG icon
12
Procter & Gamble
PG
$341B
$1.15M 2.54%
15,265
-9,380
-38% -$746K
BA icon
13
Boeing
BA
$185B
$1.02M 2.25%
8,700
-20,184
-70% -$2.17M
INTC icon
14
Intel
INTC
$507B
$897K 1.98%
39,155
-60,975
-61% -$1.4M
BP icon
15
BP
BP
$108B
$891K 1.96%
25,930
-26,328
-50% -$903K
DUK icon
16
Duke Energy
DUK
$96.1B
$879K 1.94%
13,156
-10,560
-45% -$720K
ROK icon
17
Rockwell Automation
ROK
$49.1B
$866K 1.91%
8,100
-6,184
-43% -$604K
RTX icon
18
RTX Corp
RTX
$299B
$845K 1.86%
12,448
DD icon
19
DuPont de Nemours
DD
$19.7B
$841K 1.85%
8,649
-11,987
-58% -$1.12M
TGT icon
20
Target
TGT
$67.3B
$806K 1.78%
12,600
-14,100
-53% -$960K
VZ icon
21
Verizon
VZ
$194B
$771K 1.7%
16,512
-11,408
-41% -$557K
CL icon
22
Colgate-Palmolive
CL
$74.2B
$676K 1.49%
11,400
-10,100
-47% -$598K
JPM icon
23
JPMorgan Chase
JPM
$949B
$624K 1.37%
12,075
-26,280
-69% -$1.41M
T icon
24
AT&T
T
$161B
$619K 1.36%
24,223
-28,460
-54% -$747K
EMR icon
25
Emerson Electric
EMR
$87.8B
$618K 1.36%
9,545
-16,966
-64% -$1.04M

Similar funds

Wilson Kemp & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Wilson Kemp & Associates held 89 positions worth $45.4M, down 57% from $105M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Wilson Kemp & Associates withdrew a net $61.5M in Q3 2013, closing 26 positions and reducing 59 holdings. Its most notable exit was Eli Lilly, an estimated $759K position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Wilson Kemp & Associates's biggest Q3 2013 reduction was ExxonMobil, cutting an estimated $4.43M.
  • Wilson Kemp & Associates fully exited Eli Lilly in Q3 2013, selling an estimated $759K.
  • Wilson Kemp & Associates's ten largest holdings make up 42% of its $45.4M portfolio in Q3 2013.
  • Wilson Kemp & Associates opened 0 new positions and closed 26 in Q3 2013.
  • Wilson Kemp & Associates's portfolio value fell 57% quarter-over-quarter to $45.4M.

Based on Wilson Kemp & Associates's 13F filing for Q3 2013, filed 21 Oct 2013.